108PA pilot case-control study of second or third-line treatment with cetuximab-containing chemotherapy (cetux-chemo) in patients (pts) with metastatic colorectal cancer (mCRC) who were previously treated with cetux-chemo. (25th November 2018) - Ho, C S; Cheng, A C; Li, L; Ho, W M; Hui, E P; To, K F; Tong, J H M; Ma, B B Y